Lantern Pharma LTRN
NASDAQ LTRN
$0.64 -0.03 (-4.05%)
At close: Oct 19, 2026 · 4:00 PM EDT

Lantern Pharma (LTRN) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Lantern Pharma (LTRN) posted Depreciation & Amortization (CF) of $3,751 for Q2 2026, down 16.7% from $4,501 a year earlier and down 2.6% from the prior quarter.

Analysis

Lantern Pharma (LTRN) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Lantern Pharma was $15,809, down 12.4% year-over-year; for FY2025, it was $17,280, unchanged from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 38.5% (FY2020 to FY2025).
  • In prior years, Lantern Pharma's Depreciation & Amortization (CF) was $17,282 in FY2024 (+18.2%), $14,615 in FY2023 (+45.0%), $10,081 in FY2022 (+49.1%) and $6,761 in FY2021 (+99.6%).
  • The Q2 2026 figure stands as the lowest quarterly Depreciation & Amortization (CF) since Q3 2023.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last four quarters, with growth averaging 0.3% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2021, with growth of 82.2%; the weakest was Q2 2026, with a decline of 16.7%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $3,853 (Q1 2026), $4,103 (Q4 2025) and $4,102 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 1.96 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 194.00 Mn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn -
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 1.93 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 98.00 Mn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 1.62 Bn
10 Lantern Pharma 7.95 Mn -28.21 Mn - 3,751.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,751.00
Mar 31, 2026 3,853.00
Dec 31, 2025 4,103.00
Sep 30, 2025 4,102.00
Jun 30, 2025 4,501.00
Mar 31, 2025 4,574.00
Dec 31, 2024 4,574.00
Sep 30, 2024 4,389.00
Jun 30, 2024 4,258.00
Mar 31, 2024 4,061.00
Dec 31, 2023 3,975.00
Sep 30, 2023 3,711.00
Jun 30, 2023 3,511.00
Mar 31, 2023 3,418.00
Dec 31, 2022 2,760.00
Sep 30, 2022 2,947.00
Jun 30, 2022 2,385.00
Mar 31, 2022 1,989.00
Dec 31, 2021 1,991.00
Sep 30, 2021 1,847.00
API Access

Lantern Pharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=LTRN&period=max&api_key=YOUR_API_KEY